Doctor profile · Federal record

Dr. Robert Reynolds, MD

Hematology & Oncology Physician (CMS: Medical Oncology) · Oklahoma City, OK

  • NPI 1649275827
  • Accepts Medicare
  • MIPS 81.0 / 100 · 2023
  • 30 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
13301 N Meridian Ave, Ste 501
Oklahoma City, OK 731209368
(405) 752-0871
fax (405) 755-9510

Credentials & registration

NPPES · NUCC
NPI registered
June 2005 — 21 yrs on file
Profile last updated
July 8, 2007
Year of graduation
1996 — 30 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Oklahoma #20272
Medicaid
OK #100091560A

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1649275827. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
52,225
Distinct HCPCS
10
Medicare allowed
$1,418,500
HCPCS Description Services Patients Avg allowed
J9271 Injection, pembrolizumab, 1 mg 16,400 13 $54
J1453 Injection, fosaprepitant, 1 mg 14,100 26 $0
J0897 Injection, denosumab, 1 mg 5,640 22 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,316 50 $0
J1437 Injection, ferric derisomaltose, 10 mg 3,200 25 $21
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,541 17 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,458 306 $8
J2469 Injection, palonosetron hcl, 25 mcg 1,330 33 $1
99213 Established patient office or other outpatient visit, 20-29 minutes 1,302 350 $85
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg 576 13 $119

In context: peer comparison

Among 24 peers in this city , average services per provider: 459. This provider delivers 114× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,032
Transactions
102
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 11 $329.82
PFIZER INC. 16 $262.78
Merck Sharp & Dohme LLC 9 $184.35
ABBVIE INC. 10 $178.10
Novartis Pharmaceuticals Corporation 8 $150.71
Celgene Corporation 8 $135.31
Genentech USA, Inc. 6 $119.87
E.R. Squibb & Sons, L.L.C. 5 $106.18
GlaxoSmithKline, LLC. 6 $100.38
Astellas Pharma US Inc 5 $98.59
AstraZeneca Pharmaceuticals LP 5 $97.43
GENZYME CORPORATION 3 $90.57
Takeda Pharmaceuticals U.S.A., Inc. 3 $79.60
Gilead Sciences, Inc. 4 $72.97
SOBI, INC 3 $71.43

By nature of payment

Food and Beverage
$2,930
Education
$102

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,069
Patients
269
Total drug cost
$164,465
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 154 45 $4,859
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 142 15 $5,601
Anastrozole Generic 137 26 $2,433
Prednisone Generic 89 23 $775
Eliquis (Apixaban) Brand 81 11 $53,798
Ondansetron Odt (Ondansetron) Brand 66 32 $1,365
Dexamethasone Generic 58 29 $1,124
Ondansetron Hcl Generic 58 16 $832
Abiraterone Acetate Generic 54 0 $90,262
Hydroxyurea Generic 46 0 $1,315

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Robert Reynolds's medical specialty?
Dr. Robert Reynolds practices Hematology & Oncology Physician in Oklahoma City, OK.
Where does Dr. Robert Reynolds practice?
Dr. Robert Reynolds practices at 13301 N Meridian Ave, Oklahoma City, OK 731209368. Office phone: 4057520871.
What is Dr. Robert Reynolds's NPI?
Dr. Robert Reynolds's National Provider Identifier (NPI) is 1649275827, issued by NPPES.
Does Dr. Robert Reynolds accept Medicare assignment?
Yes. Dr. Robert Reynolds accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Robert Reynolds commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.